13 results
6-K
EX-1.1
SPRC
SciSparc Ltd
14 Aug 23
SciSparc Ltd. Announces Pricing of $1.3 Million Underwritten Public Offering
4:31pm
inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar … , that the Underwriter of the Securities is an “Acquiring Person” under any control share acquisition, business combination, poison pill (including any
6-K
EX-99.1
SPRC
SciSparc Ltd
16 May 23
At-The-Market Issuance Sales Agreement
8:06pm
, or any other rights (whether pursuant to a “poison pill” provision or otherwise) to purchase any Ordinary Shares or shares of any other share capital
6-K
EX-99.2
SPRC
SciSparc Ltd
27 May 22
SciSparc Announces Pricing of $10 Million Private Placement Priced At-the-Market
4:10pm
of Directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including … is an “Acquiring Person” under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar
6-K
EX-99.2
SPRC
SciSparc Ltd
2 Mar 21
Report of Foreign Private Issuer
4:05pm
have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any … acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement
F-1/A
EX-4.6
SPRC
SciSparc Ltd
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Company’s … , any other Person, that any Purchaser is an “Acquiring Person” under any control share acquisition, business combination, poison pill (including any
F-1/A
EX-1.1
6euunv1c3kntly4m
9 Oct 20
Registration statement (foreign) (amended)
12:00am
6-K
EX-99.3
qwf 337qaroq
1 Jul 20
Report of Foreign Private Issuer
9:05am
F-1/A
EX-4.7
nqoe 4mdet0zaulv83x4
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
EX-4.7
v1z2qd x6p7w
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
EX-4.7
wkwubw
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
6-K
EX-10.1
4yfhxst zb5lwl5i2y
4 Dec 19
Therapix Biosciences Announces Pricing of $1,250,000 Registered Direct Offering
9:26am
6-K
EX-10.1
esk5qnoslc8g mtu
28 Mar 19
Therapix Biosciences Announces Pricing
8:51am
6-K
EX-10.1
0txyn4e
27 Nov 18
Therapix Biosciences Issues $1,500,000 Convertible Debenture
8:01am
- Prev
- 1
- Next